Home » Topics » Regulatory

Regulatory
RSS

FDA approves Enbrel for JRA

June 2, 1999

Suplatast tosilate, a novel mediator release inhibitor with potential in the treatment of IC

June 2, 1999

New cholesterol-binding agent on the road to launch in Japan

June 1, 1999

CPMP recommends expanded approval of Temodal for brain tumor therapy

May 31, 1999

Fragmin approved in U.S. for treatment of unstable angina and non-Q wave MI

May 31, 1999

Noven's transdermal patch for ADHD Rx shows promise in initial clinical study

May 31, 1999

Use of ET antagonists for transplant rejection described by Knoll

May 27, 1999

New dose of Baycol approved in the U.S. for treatment of hypercholesterolemia

May 27, 1999

News from APA: bupropion SR suggested to hold promise as an antiobesity treatment

May 26, 1999

Glaxo Wellcome launches first drug to treat PPH in Japan

May 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.